| 摘要 |
<p>Use of a compound of formula (I): 5-{5-[(2,4-dimethyl-1,3-thiazol-5-yl)methyl]-1,3,4-oxadiazol-2-yl}-1-ethyl-N-(tetrahydro-2H-pyran-4-yl)-1H-pyrazolo[3,4-b]pyridin-4-amine (I) or a pharmaceutically acceptable salt thereof for the treatment of Huntington's disease.</p> |
